Glenmark Pharmaceuticals
GLENMARK.NS
$20.92
Share price
-1.05%
Change (1 day)
22.90%
Change (1 year)
Categories
Revenue for Glenmark Pharmaceuticals (GLENMARK.NS)
Revenue in 2024 (TTM): S$2.05 Billion
According to Glenmark Pharmaceuticals
's latest financial reports the company's current revenue (TTM 
) is S$2.02 Billion. an increase over the revenue in the year 2023 that were of S$1.90 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Glenmark Pharmaceuticals from 2012 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | S$2.09 B | 9.81% |
| 2023 | S$1.90 B | -3.4% |
| 2022 | S$1.97 B | -10.18% |
| 2021 | S$2.19 B | 15.63% |
| 2020 | S$1.89 B | -3.31% |
| 2019 | S$1.96 B | 5.3% |
| 2018 | S$1.86 B | -1.38% |
| 2017 | S$1.89 B | 0.36% |
| 2016 | S$1.88 B | 22.98% |
| 2015 | S$1.53 B | 9.88% |
| 2014 | S$1.39 B | 16.42% |
| 2013 | S$1.19 B | 10.48% |
| 2012 | S$1.08 B |